Oncogenic miR-9 is a target of erlotinib in NSCLCs
暂无分享,去创建一个
X. Chen | Min Li | Ping Li | Xuerong Wang | Xuan Luo | Geng Sun | Sulan Zhai | Zhuo Ma | Lingjun Zhu
暂无分享,去创建一个
X. Chen | Min Li | Ping Li | Xuerong Wang | Xuan Luo | Geng Sun | Sulan Zhai | Zhuo Ma | Lingjun Zhu